Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Featured Stories

UK Government Points At Oximeters For Contributing To Disparity In COVID-19 Outcomes

Sajid Javid, the UK’s secretary of state for health and social care, wants to collaborate with the US Department of Health and Human Services to investigate biases in monitoring and diagnostic devices.

Diversity & Inclusion Clinical Trials Diagnostics

FDA Warning Letter Prompts Company To Stop Selling Baby-Monitoring Device

For five years Owlet Baby Care Inc. has said its Smart Sock monitoring product isn’t a medical device. But the US FDA disagreed – and finally put its foot down in a warning letter that told the company to come into compliance or stop selling the sock. So Owlet decided to do both.

Pediatrics Compliance Commercial

First Belgian Notified Body Appointment Brings EU MDR Total To 25

Every new notified body designation under the Medical Device Regulation is being welcomed by medtech companies as the countdown continues for the grace period to end in May 2024.

EU Europe Belgium

Minute Insight: Current Testing Technologies Can Detect The Omicron Variant

As fears about vaccine escape grow, test manufacturers have been quick to assert that their tests can spot the new Omicron variant of SARS-CoV-2

In Vitro Diagnostics Diagnostics Coronavirus COVID-19

House COVID Subcommittee Has Questions For Former FDA Commissioner Hahn

The House Select Subcommittee on the Coronavirus Crisis wants more information on attempts by President Trump and others to influence FDA decisions on HCQ, convalescent plasma, and vaccines.

Policy Politics Coronavirus COVID-19

French Notified Body Anticipates UK Designation By Summer 2022

After the shake-up of notified bodies based in the UK in the wake of Brexit, GMED is one EU notified body that is hoping for its UK subsidiary to be designated as a UK approved body within the next six to nine months.

EU Europe Medical Device

Q3 Recalls Snapshot: Cardinal Health’s Recall Of 267 Million Syringes Causes Recalled Units To Swell

The number of recalled device units ballooned to a whopping 372,215,986 in the third quarter of 2021, mostly driven by an August recall of Monoject Flush Prefilled Saline Syringes by Cardinal Health. Check out our Q3 recalls infographic.

Recalls FDA Safety

Device Week Podcast


In This Episode:

Congenica Tries To Bring Clarity To Personalized Medicine For Rare Diseases

Listen to Medtech Insight podcasts for our perspectives on regulation, policy, quality, R&D and key commercial topics. >More Podcasts


Recent Tweets from Medtech Insight

Latest from PR Newswire

Click here to access further medical device and diagnostics news.

Policy & Regulation Explore this Topic

Set Alert for Policy & Regulation

FDA’s New Inspections Council Whipping Up Policy Around Remote Regulatory Assessments

The US FDA says in a report that its Inspectional Affairs Council will develop Remote Regulatory Assessment policies for all commodities the agency oversees. RRAs were launched by the FDA as a way to check on a firm’s regulatory compliance without sending an investigator on-site.

Policy Enforcement FDA

App Developers Turning To HIPAA Compliance In Face Of Growing State Data Privacy Constraints

Manufacturers faced with an increasingly complex landscape of state patient-privacy laws may opt to comply with federal Health Insurance Portability and Accountability Act regulations instead, attorney Brad Rostolsky tells Medtech Insight.

Patient Monitoring Legal Issues Compliance

Latest From Policy & Regulation

US FDA Proposes Making It Easier To Get Certain HIV Tests To Market

Regulators say that despite millions of HIV viral load monitoring tests on the market over the past 25 years, there has only been on class II recall for the products, which warrants easing their path to market.

Regulation Policy

Three OTC COVID-19 Tests Win FDA Clearance After Template Updates

Access Bio’s CareStart COVID-19 Antigen test gives results within 10 minutes, Becton, Dickinson’s BD Veritor within 15 minutes and InBios International’s SCoV-2 Ag Detect within 20 minutes. All three hold emergency use authorizations.

Diagnostics Coronavirus COVID-19

Comments Invited on European Commission Vision For IVDR EU Reference Laboratories

Two long-awaited European Commission proposals have been published which shed light on how EU reference laboratories will operate under the IVD Regulation and likely timelines.

EU Europe

Podcast: How Do You Protect Yourself When Your AI Makes Mistakes?

Medtech Insight spoke with Sidley Austin attorneys about the future of medical device AI negligence litigation and what manufacturers can do to protect themselves.

Policy Commercial

Minute Insight: HHS Gets $35M Shot In Arm To Expand Telehealth For Family Planning

The US Department of Health and Human Services said on 23 November that the money will be used “to enhance and expand the telehealth infrastructure and capacity of Title X family planning providers.”

Telehealth Policy

Infusion Pump Testing Takes Center Stage In TIR Guidance From AAMI

The Association for the Advancement of Medical Instrumentation’s new technical information report guides pump makers as they test their devices for a variety of clinical scenarios and conditions. TIR101:2021 also tackles flow rates, metrics, labeling, and more.

Standards International

Quality Control & Compliance Explore this Topic

Set Alert for Quality Control

Latest From Quality Control

FDA Posts Study Confirming OD Risk From ENFit LDT Syringes

The US FDA has posted a study affirming a safety communication the agency issued in October that warned of overdose risk from certain low dose tip syringes.

Safety FDA

FDA Warns Of Severe Risks Associated With Medtronic Leadless Pacemakers

The US Food and Drug Administration has issued a warning to clinicians of the heightened risk for adverse events, including death, from potential cardiac perforation during implantation of Medtronic’s Micra Transcatheter Pacing System (TPS).

Safety FDA

After High-Risk Recall And Scathing Inspection Report, Is FDA Warning Letter Next For Philips?

Industry experts weigh in on what the US FDA’s enforcement options are following the company’s high-profile recall of millions of breathing devices and unfavorable facility inspection results.

Enforcement FDA

OUTLOOK 2021

Forward-looking features and special content, including Scrip 100, Medtech 100 and Generics Top 50 industry rankings

VIEW NOW

Commercial Explore this Topic

Set Alert for Commercial

Exec Chat: Alcon Seeks Vision ‘Utopia’ For Cataract Surgery Patients

Jeannette Bankes, the general manager of Alcon’s global surgical business, talked to Medtech Insight about how the company is addressing the cataract surgery market with a range of intraocular lenses intended to return the patients vision to as close to its natural optimal function as possible.

Exec Chats Ophthalmic Surgery

Latest From Commercial

Podcast: How Do You Protect Yourself When Your AI Makes Mistakes?

Medtech Insight spoke with Sidley Austin attorneys about the future of medical device AI negligence litigation and what manufacturers can do to protect themselves.

Policy Commercial

Exec Chat: Medtronic’s Linnea Burman Targets 'Consensus-Driven Care' Using AI, Robotics In Spine Care

Linnea Burman, the general manager of enabling technologies for cranial and spinal technologies at Medtronic, talked to Medtech Insight about plans for the Mazor spinal robotic system, the incoming new president of the division, and other new developments.

Exec Chats Business Strategies

Execs On The Move: Endologix Gets New CEO, Medtronic Appoints New Head Of Global Strategy

Bob Hopkins, previously the managing director at Bank of America Merrill Lynch, is now Medtronic's head of global strategy.

Commercial Companies

Device Week, 19 November 2021 – J&J Break-Up, And Genomic Diagnostics

On this episode of Device Week, Medtech Insight’s Marion Webb explains the recent announcement that Johnson & Johnson will split into two separate businesses – one focusing on medical products, and the other focusing on consumer. Barnaby Pickering discusses recent results from the UK’s 100,000 Genome project, and how its analysis partner, Congenica, hopes to deliver personalized medicine through widescale genomic testing.

Device Week Diagnostics

Angle Outlines Strategy As It Nears Major Regulatory Announcements

With approvals looming over the next few months, Angle spoke to Medtech Insight to probe deeper about its presentation at the 2021 Jefferies Healthcare Conference.

In Vitro Diagnostics Personalized Medicine

Cala Health Hopes To Jolt Essential Tremor Market With Wrist-Worn Non-Invasive Stimulation

Cala Health’s FDA-cleared Cala Trio wearable for treating essential tremor is currently being tested in Parkinson’s disease patients and is targeting a $20bn global market opportunity.

Start-Up Spotlight Digital Health

Clinical R&D Explore this Topic

Set Alert for Clinical R&D

FDA To Impose Premarket Requirements On Blood Lancets

Single-patient lancets will face new special controls and 510(k) submission, while multiple-patient lancets would require a PMA.

Regulation FDA Safety

Latest From Research & Development

Exec Chat: Medtronic’s Linnea Burman Targets 'Consensus-Driven Care' Using AI, Robotics In Spine Care

Linnea Burman, the general manager of enabling technologies for cranial and spinal technologies at Medtronic, talked to Medtech Insight about plans for the Mazor spinal robotic system, the incoming new president of the division, and other new developments.

Exec Chats Business Strategies

AI Expert: Awareness Is Key To Managing Biases

A Walden University professor discussed various types of biases AI/ML developers need to take into consideration during the recent Xavier Health AI Summit. She noted a working group will produce a white paper laying out different types of biases to raise awareness.

Research & Development Artificial Intelligence

Cala Health Hopes To Jolt Essential Tremor Market With Wrist-Worn Non-Invasive Stimulation

Cala Health’s FDA-cleared Cala Trio wearable for treating essential tremor is currently being tested in Parkinson’s disease patients and is targeting a $20bn global market opportunity.

Start-Up Spotlight Digital Health

Minute Insight: Siemens Healthineers Launches The World's First Photon-Counting CT Scanner

Naeotom Alpha will allow for faster, more precise, and safer computed tomography imaging for cardiac imaging, oncology, and pulmonology.

Minute Insights Launches

Virtual MRI Tool Added To FDA Developer Resources

The computer-based software helps predict how devices will react to increased temperature in MRI machines.

Regulation FDA

Cardiovascular Catch-Up: Medtronic And Edwards Make Headlines At TCT Conference

The first half of November was full of cardiovascular device news, led by clinical trial results from renal denervation and transcatheter aortic valve trials presented at the Transcatheter Cardiovascular Therapeutics (TCT) conference.

Clinical Trials Research & Development
UsernamePublicRestriction

Register